Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Outcome of Board Meeting of the Company held ....
BAYERCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts less than Nifty Smallcap 250 and 3.7 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Bayer CropScience approved unaudited financial results for the quarter ended June 30, 2025. Revenue from operations rose to ₹19,146 Mn from ₹16,314 Mn in the same quarter last year, a growth of about 17%. Profit for the period stood at ₹2,787 Mn versus ₹2,542 Mn a year ago, up roughly 10%. Earnings per share came in at ₹62.01 (not annualised) compared to ₹56.56 earlier. Total income increased to ₹19,333 Mn, while total expenses rose to ₹15,981 Mn from ₹13,429 Mn. Deloitte Haskins & Sells LLP issued a clean limited review report with no qualifications.
A steady quarter with double-digit revenue and profit growth, supported by the company's seasonal agri-care business. The clean auditor review and no flagged risks suggest business is on a stable track, though full-year performance depends on the upcoming cropping season.